Hetrombopag for the Enhancement of Platelet Engraftment After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT05727917 · UNKNOWN
Trial details
- NCT number
- NCT05727917
- Sponsor
- Institute of Hematology & Blood Diseases Hospital, China
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-01
- Primary completion
- 2024-05-31
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.